COVID-19 impact on oncology clinical trials: a 1-year analysis.

Upadhaya, Samik; Yu, Jia Xin; Hodge, Jeffrey; Campbell, Jay

Upadhaya, Samik; Yu, Jia Xin; Hodge, Jeffrey; Campbell, Jay.

Nat Rev Drug Discov ; 20(6): 415, 2021 06.

Article in English | MEDLINE | ID: covidwho-1291973

Subject(s)

COVID-19; Clinical Trials as Topic; Early Termination of Clinical Trials; Medical Oncology/methods; Neoplasms/therapy; Biomedical Research/organization & administration; Biomedical Research/trends; COVID-19/epidemiology; COVID-19/prevention & control; Clinical Trials as Topic/classification; Clinical Trials as Topic/organization & administration; Clinical Trials as Topic/statistics & numerical data; Communicable Disease Control/methods; Early Termination of Clinical Trials/adverse effects; Early Termination of Clinical Trials/statistics & numerical data; Forecasting; Humans; Observational Studies as Topic/statistics & numerical data; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / Early Termination of Clinical Trials / COVID-19 / Medical Oncology / Neoplasms Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Nat Rev Drug Discov Journal subject: Pharmacology / Drug Therapy Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google